“This stock has made me much better off than I a
Post# of 148282
The 140 patient trial will demonstrate a stat significant benefit for a reduction in length of hospitalization and could possible show a reduction in mortality as well. That should get the SP above $10 and lead to trials for ARDS, influenza, etc.